Mercedes describes its upgrade for the upcoming U.S. Grand Prix at Circuit of The Americas as “a fairly substantial set of ...

IMTOZ trial findings and subsequent approval of Isa-VRd regimen for transplant-ineligible myeloma suggested the combo as a ...

International Myeloma Society Annual Meeting was a groundbreaking event that showcased the latest advancements in multiple ...

Bhubaneswar: The Institute of Medical Sciences and SUM Hospital, faculty of medicine of Siksha ‘O’ Anusandhan Deemed to be ...

A three-day national workshop at the Institute of Medical Sciences, BHU, focused on hands-on training in diagnosing fungal diseases. With 35 participants, experts provided practical experience and ...

Data from the study with the lead ADC candidate, HDP-101, show elimination of tumor cells in one patientClinical data from IMS will be presented in R&D webinar on 15 October at 17:00 CEST / 11:00 ...

"Cilta-cel is the first CAR T-cell therapy to demonstrate an overall survival benefit in multiple myeloma," María-Victoria ...

Poseida Therapeutics' lead allogeneic chimeric antigen receptor T-cell candidate it is co-developing with Roche will advance to Phase Ib.

A proposed Formula 1 race for rookie drivers at the end of the season has been pushed back to 2025 due to timing constraints, ...

The VITA 67 standards encompass a range of VPX-based coaxial interconnects. Specifically, the VITA 67.3 standard addresses ...

TIAA, the retirement giant for university professors and other non-profits, is the latest big firm to report clients’ private ...

Speakers at the 2024 International Myeloma Society (IMS) conference share the updates from the myeloma space that they were ...